» Articles » PMID: 25955580

Association of Preoperative US Features and Recurrence in Patients with Classic Papillary Thyroid Carcinoma

Overview
Journal Radiology
Specialty Radiology
Date 2015 May 9
PMID 25955580
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate whether ultrasonographic (US) features of thyroid nodules are associated with tumor recurrence in classic papillary thyroid carcinoma (PTC).

Materials And Methods: This retrospective study was approved by the Institutional Review Board, and the need to obtain informed consent was waived. A total of 515 patients (mean age, 45.8 years ± 13.2 [standard deviation]; range, 17-80 years) who underwent total thyroidectomy and central lymph node dissection for classic PTC greater than 10 mm from January 2003 to February 2006 and who were followed up for 12 months or longer were included. Malignant-appearing PTCs were defined as those showing at least one suspicious US feature among marked hypoechogenicity, irregular or microlobulated margin, microcalcifications, and taller-than-wide shape. Benign-appearing PTCs were defined as those without any suspicious US features. Kaplan-Meier cumulative-event curves for recurrence were compared by using the log-rank test. The multivariate Cox proportional hazard regression analysis was used to estimate hazard ratios (HRs) of the malignant-appearing US features for recurrence in the preoperative, postoperative, and combined models.

Results: Fifty-six (10.9%) of 515 patients had recurrence. Malignant-appearing PTCs had lower 5- and 10-year disease-free survival rates compared with benign-appearing PTCs (P = .01). In the preoperative model, malignant-appearing US features (HR, 3.523; 95% confidence interval [CI]: 1.263, 9.830) and larger nodule size (HR, 1.074; 95% CI: 1.051, 1.098) were independently associated with recurrence. In the combined model, male sex (HR, 1.990; 95% CI: 1.098, 3.610), malignant-appearing US features (HR, 2.828; 95% CI: 1.016. 7.870), larger nodule size (HR, 1.067; 95% CI: 1.043, 1.092), extrathyroidal extension (HR, 2.590; 95% CI: 1.160, 5.780), and lymph node metastasis (HR, 2.511; 95% CI: 1.163, 5.421) were independently associated with recurrence.

Conclusion: The presence of malignant-appearing US features was independently associated with recurrence in patients with classic PTC.

Citing Articles

Ultrasound-based nomogram to predict the recurrence in papillary thyroid carcinoma using machine learning.

Zhou B, Liu J, Yang Y, Ye X, Liu Y, Mao M BMC Cancer. 2024; 24(1):810.

PMID: 38972977 PMC: 11229345. DOI: 10.1186/s12885-024-12546-6.


Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation.

Kim M, Park H, Oh Y, Shin J, Kim T, Hahn S Korean J Radiol. 2024; 25(1):103-112.

PMID: 38184773 PMC: 10788599. DOI: 10.3348/kjr.2023.0461.


Integration of ultrasound-based radiomics with clinical features for predicting cervical lymph node metastasis in postoperative patients with differentiated thyroid carcinoma.

Fan F, Li F, Wang Y, Dai Z, Lin Y, Liao L Endocrine. 2023; 84(3):999-1012.

PMID: 38129723 PMC: 11208252. DOI: 10.1007/s12020-023-03644-9.


Analysis of preoperative computed tomography radiomics and clinical factors for predicting postsurgical recurrence of papillary thyroid carcinoma.

Xu H, Wu W, Zhao Y, Liu Z, Bao D, Li L Cancer Imaging. 2023; 23(1):118.

PMID: 38098119 PMC: 10722708. DOI: 10.1186/s40644-023-00629-9.


Clinical and Pathological Characteristics of Patients With Papillary Thyroid Carcinoma Coexisting With Hashimoto's Thyroiditis: A Retrospective Cohort Study.

Yang Y, Liu J, Shi X, Wang M Cancer Control. 2023; 30:10732748231199647.

PMID: 37643366 PMC: 10467246. DOI: 10.1177/10732748231199647.